Thermo Fisher Scientific (TMO) shares took off after the maker of lab equipment and other life sciences products posted better-than-expected results and boosted its guidance, citing operational improvements and lower expected impacts from new tariffs.
Shares of Thermo Fisher Scientific Inc (NYSE:TMO, ETR:TN8) jumped nearly 12% on Wednesday morning after the company reported second-quarter results that topped Wall Street estimates, fueled by strong demand across its life sciences and diagnostics segments. The company posted revenue of $10.86 billion, surpassing analysts' expectations of $10.69 billion and marking a 3% year-over-year increase.
TMO tops Q2 estimates as new product launches and solid segment growth fuel revenue gains despite margin pressure.
![]() TMO In 1 month Announced | Quarterly | $0.43 Per Share |
![]() TMO 1 month ago Paid | Quarterly | $0.43 Per Share |
![]() TMO 4 months ago Paid | Quarterly | $0.43 Per Share |
![]() TMO 7 months ago Paid | Quarterly | $0.39 Per Share |
![]() TMO 10 months ago Paid | Quarterly | $0.39 Per Share |
22 Oct 2025 (In 2 months) Date | | 5.52 Cons. EPS | - EPS |
22 Oct 2025 (In 2 months) Date | | 5.49 Cons. EPS | - EPS |
22 Jul 2025 Date | | 5.23 Cons. EPS | 5.36 EPS |
22 Apr 2025 Date | | - Cons. EPS | - EPS |
31 Jan 2025 Date | | 5.94 Cons. EPS | 6.1 EPS |
![]() TMO In 1 month Announced | Quarterly | $0.43 Per Share |
![]() TMO 1 month ago Paid | Quarterly | $0.43 Per Share |
![]() TMO 4 months ago Paid | Quarterly | $0.43 Per Share |
![]() TMO 7 months ago Paid | Quarterly | $0.39 Per Share |
![]() TMO 10 months ago Paid | Quarterly | $0.39 Per Share |
22 Oct 2025 (In 2 months) Date | | 5.52 Cons. EPS | - EPS |
22 Oct 2025 (In 2 months) Date | | 5.49 Cons. EPS | - EPS |
22 Jul 2025 Date | | 5.23 Cons. EPS | 5.36 EPS |
22 Apr 2025 Date | | - Cons. EPS | - EPS |
31 Jan 2025 Date | | 5.94 Cons. EPS | 6.1 EPS |
Medical - Diagnostics & Research Industry | Healthcare Sector | Marc N. Casper CEO | XETRA Exchange | US8835561023 ISIN |
US Country | 125,000 Employees | 15 Sep 2025 Last Dividend | 6 Jun 1996 Last Split | 13 Jan 1978 IPO Date |
Thermo Fisher Scientific Inc. is a global leader in serving science, offering a wide range of products and services across life sciences, analytical instruments, specialty diagnostics, and laboratory products, as well as biopharma services. The company boasts a broad presence, serving customers in North America, Europe, the Asia-Pacific region, and internationally. Its offerings are designed to cater to the needs of the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. By delivering solutions that support research and development, diagnostics, and the production of drugs and vaccines, Thermo Fisher Scientific plays a pivotal role in advancing public health and scientific endeavors worldwide. Founded in 1956, the company is headquartered in Waltham, Massachusetts.
This segment provides a variety of reagents, instruments, and consumables used in biological and medical research, the discovery and production of drugs and vaccines, and the diagnosis of infections and diseases. The offerings encompass biosciences, genetic sciences, and bio production and are tailored for markets including pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government sectors.
Includes instruments, consumables, software, and services suited for a wide range of applications in the pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. These instruments and services facilitate complex analyses and experiments.
This segment offers a variety of diagnostic products and services, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments. It covers the needs of the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; offers dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; provides human leukocyte antigen typing and testing for the organ transplant market; and supplies healthcare products.
Provides an extensive array of laboratory products and services, including research and safety market channel and pharma services and clinical research, catering to various scientific needs. The segment supports the research, development, and production processes across the scientific community.
The company offers these products and services through a combined approach of a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, and Patheon and PPD brands.